Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
24.80
+0.37 (1.51%)
At close: Apr 28, 2026, 4:00 PM EDT
24.80
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Agios Pharmaceuticals Market Cap
Agios Pharmaceuticals has a market cap or net worth of $1.45 billion as of April 28, 2026. Its market cap has increased by 0.20% in one year.
Market Cap
1.45B
Enterprise Value
323.00M
1-Year Change
0.20%
Ranking
Category
Stock Price
$24.80
Market Cap Chart
Since July 24, 2013, Agios Pharmaceuticals's market cap has increased from $919.00M to $1.45B, an increase of 58.12%. That is a compound annual growth rate of 3.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.43B | -9.82% |
| Dec 31, 2025 | 1.59B | -15.30% |
| Dec 31, 2024 | 1.87B | 50.56% |
| Dec 29, 2023 | 1.24B | -19.33% |
| Dec 30, 2022 | 1.54B | -13.57% |
| Dec 31, 2021 | 1.79B | -40.52% |
| Dec 31, 2020 | 3.00B | 6.73% |
| Dec 31, 2019 | 2.81B | 4.81% |
| Dec 31, 2018 | 2.68B | -3.76% |
| Dec 29, 2017 | 2.79B | 58.97% |
| Dec 30, 2016 | 1.75B | -28.25% |
| Dec 31, 2015 | 2.44B | -37.12% |
| Dec 31, 2014 | 3.89B | 420.55% |
| Dec 31, 2013 | 746.50M | -18.77% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immatics | 1.52B |
| MBX Biosciences | 1.52B |
| Damora Therapeutics | 1.49B |
| Immunocore Holdings | 1.49B |
| Biohaven | 1.49B |
| Bicara Therapeutics | 1.48B |
| Precigen | 1.46B |
| Ardelyx | 1.46B |